HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...
MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. | MapLight Therapeutics is ...
MEDFORD, Mass.--(BUSINESS WIRE)--Myrobalan Therapeutics, a biotechnology company developing novel oral neurorestorative therapies to repair damage and restore neural function in high-unmet need ...
Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling. A pivotal trial failed to show benefit, and they had several other clinical failures as ...
Accomplished physician-scientist brings more than 30 years of industry leadership experience and CNS drug development expertise. SEATTLE, April 29, 2025 /PRNewswire/ -- Transneural Therapeutics, Inc. ...
14don MSN
How the cerebellum builds its connections with the rest of the brain during early development
For the first time, a team of researchers at the Institute for Neurosciences (IN), a joint center of the Spanish National ...
AZoLifeSciences on MSN
Stem cell models offer insights into early brain development and autism
Researchers have made great strides to understand early signs of autism. Studies have found that certain factors like ...
A new study in the lab of Jason Stein, Ph.D., modeled brain development in a dish to identify cells and genes that influence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback